Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DNX Ventures, formerly known as Draper Nexus, is a venture capital firm that specializes in early-stage B2B startups, particularly in the SaaS, cybersecurity, and deep tech sectors. Founded in 2011, the firm operates with a unique cross-border strategy, bridging the innovation ecosystems of Silicon Valley and Japan. DNX Ventures provides not only capital but also strategic support and market access to its portfolio companies through an extensive network of corporate partners. While the firm is not a biotechnology or pharmaceutical company, it plays a significant role in the technology landscape, investing in innovations that transform industries. The firm is a member of the Draper Venture Network, founded by Tim Draper.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Draper Nexus.